Tag Archives: fosamax
Bone fractures caused by osteoporosis drugs under FDA investigation
The FDA is investigating increased bone fracture and jawbone death risk associated with bisphosphonates prescribed to treat osteoporosis. In response to the same concerns raised by ABC News and this blog in March 2010, the FDA has scheduled a September 2011 meeting to … Continue reading
Posted in Defective Drugs, Fosamax, bone fractures
Tagged actonel, atelvia, biphosphonates, boniva, fosamax, osteoporosis, reclast
Fosamax found to weaken bones rather than strengthen them
Doctors are reporting increases in unusual bone fractures over the past 18 months in patients taking the Merck osteoporosis drug Fosamax (alendronate). As pressure increases for the Merck or the FDA to act, doctors say they are seeing more patients … Continue reading
Posted in Defective Drugs
Tagged bone-fractures, Defective Drugs, fosamax, merck